SlideShare a Scribd company logo
Pharmaceutical
Incompatibilities.
Presented by
Prof. Sudipta Roy
Definition of Incompatibility.
Incompatibility:
Formation of Changed and Undesirable product.
There are three types of Pharmaceutical
Incompatibilities seen due to changes and
undesirable effects-Physical,Chemical and
therapeutic incompatibilities to affect the
safety,efficacy, appearance and stability of the
product.
Reasons of Pharmaceutical
Incompatibilities.
• Formation of Undesirable product are due to
• Compounding
• Formulation
• Manufacturing
• Packaging
• Dispensing
• Storage
• Administration of drugs
The pharmaeutical incompatibilities may be changed
due to physical, chemical, and therapeutic qualities
of the medicine.
Physical incompatibilities.
• Two or more than two substances are combined, a
physical change takes place and unacceptable
product is formed.
• Interaction between two or more substances lead
to change in color, odor , taste , viscosity and
morphology.
Reasons of Physical
Incompatibility.
Insolubility:-Insolubility of prescribed agents in
vehicle.
Immiscibility:-Immiscibility of two or more liquids.
Precipitation:-It occurs due to solvent is insoluble
when it is added to solution.
Liquefaction:-Liquefaction of solids mixed in a dry
state (called eutexia).
• INSOLUBILITY
• Materials are not dissolved in particular solvent system.
• Incompatibilities are due to insolubility of the inoeganic and
organic compounds in particular solvent.
• These are factors that affect insolubility.
• Change in PH
• Milling
• Surfactant
• Chemical reaction
• Complex formation
• Co-solvent
Common Examples of Diffusible Solids:
Substances like chalk, acetyl salicylic acid ,succinyl
sulphothiazzole, zinc oxide, and calamine etc.
Tinctures containing resins or chlorophyll gets
precipitated when added to the aqueous system.
E.g.:-Mixture of prepared chalk
Rx
Chalk powder –2g
Tincture catechu – 2ml
Cinnamon water – 2ml
Causes: - Chalk powder is insoluble in water , due to
this It gets precipitated into aqueous
medium,diffusible in nature which results in physical
incompatibility.
Remedy: - Use of suspending agents are necessary to
suspend the precipitated chalk particles.
Generally 2% W/V of compound tragacanth powder
is recommended as suspending agent.
• The corrected prescription is Mixture of prepared
chalk
• Rx
• Chalk powder –2g
• Tragacanth – 0.4g
• Tincture catechu – 2ml
• Cinnamon water up to 30ml

More Related Content

Similar to Pharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptx

Pharmaceutical incompatibilities
Pharmaceutical incompatibilitiesPharmaceutical incompatibilities
Pharmaceutical incompatibilities
Zainab&Sons
 
Incompatibilities in prescriptions
Incompatibilities in prescriptionsIncompatibilities in prescriptions
Incompatibilities in prescriptions
PRAVEEN KUMAR CHEMBETI
 
Pharmaceutical Incompatibility : Mr. P. B. Jadhav
Pharmaceutical Incompatibility : Mr. P. B. JadhavPharmaceutical Incompatibility : Mr. P. B. Jadhav
Pharmaceutical Incompatibility : Mr. P. B. Jadhav
PRASHANT JADHAV
 
part 2- Stability testing of herbal medicinal products 2024.pptx
part 2- Stability testing of herbal medicinal products 2024.pptxpart 2- Stability testing of herbal medicinal products 2024.pptx
part 2- Stability testing of herbal medicinal products 2024.pptx
Education
 
Incompatibilities in prescription, prescription Incompatibilities, important ...
Incompatibilities in prescription, prescription Incompatibilities, important ...Incompatibilities in prescription, prescription Incompatibilities, important ...
Incompatibilities in prescription, prescription Incompatibilities, important ...
RajkumarKumawat11
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescription
SantuMistree4
 
Pharmaceutical Incompatibility
Pharmaceutical IncompatibilityPharmaceutical Incompatibility
Pharmaceutical Incompatibility
Ravikumar Patil
 
P.formulations solutions
P.formulations    solutionsP.formulations    solutions
P.formulations solutions
Anand Addagalla
 
Drug Excipient Interaction Studies
Drug Excipient Interaction StudiesDrug Excipient Interaction Studies
Drug Excipient Interaction Studies
Kailas Mali
 
UNIT II - LIQUIDS.pptx
UNIT II -  LIQUIDS.pptxUNIT II -  LIQUIDS.pptx
UNIT II - LIQUIDS.pptx
UmarFarook93
 
Prodrug
ProdrugProdrug
Drug incompatibilities
Drug  incompatibilitiesDrug  incompatibilities
Drug incompatibilities
mostafa hosni
 
SOLUBILIZATION TECHNIQUES
SOLUBILIZATION TECHNIQUESSOLUBILIZATION TECHNIQUES
SOLUBILIZATION TECHNIQUES
Prashant Patel
 
12 incompatability
12 incompatability12 incompatability
12 incompatability
Pradeep Patil
 
Incompatibility in Prescription
Incompatibility in PrescriptionIncompatibility in Prescription
Incompatibility in Prescription
bvocmithilesh
 
Pharmaceutical incompatibility
Pharmaceutical incompatibilityPharmaceutical incompatibility
Pharmaceutical incompatibility
rohit kamboj
 
prodrug-.pptx Medicinal chemistry 7 SEMESTER
prodrug-.pptx  Medicinal chemistry 7 SEMESTERprodrug-.pptx  Medicinal chemistry 7 SEMESTER
prodrug-.pptx Medicinal chemistry 7 SEMESTER
dipika51
 
Accelerated Stability Testing.
Accelerated Stability Testing. Accelerated Stability Testing.
Accelerated Stability Testing.
Maha Alkhalifah
 
Drug excipient compatibility
Drug excipient compatibilityDrug excipient compatibility
Drug excipient compatibility
Rx Ayushi Patel
 
Oral Solutions Dr.pptx
Oral Solutions Dr.pptxOral Solutions Dr.pptx
Oral Solutions Dr.pptx
Dr. Samia
 

Similar to Pharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptx (20)

Pharmaceutical incompatibilities
Pharmaceutical incompatibilitiesPharmaceutical incompatibilities
Pharmaceutical incompatibilities
 
Incompatibilities in prescriptions
Incompatibilities in prescriptionsIncompatibilities in prescriptions
Incompatibilities in prescriptions
 
Pharmaceutical Incompatibility : Mr. P. B. Jadhav
Pharmaceutical Incompatibility : Mr. P. B. JadhavPharmaceutical Incompatibility : Mr. P. B. Jadhav
Pharmaceutical Incompatibility : Mr. P. B. Jadhav
 
part 2- Stability testing of herbal medicinal products 2024.pptx
part 2- Stability testing of herbal medicinal products 2024.pptxpart 2- Stability testing of herbal medicinal products 2024.pptx
part 2- Stability testing of herbal medicinal products 2024.pptx
 
Incompatibilities in prescription, prescription Incompatibilities, important ...
Incompatibilities in prescription, prescription Incompatibilities, important ...Incompatibilities in prescription, prescription Incompatibilities, important ...
Incompatibilities in prescription, prescription Incompatibilities, important ...
 
Incompatibilities in prescription
Incompatibilities in prescriptionIncompatibilities in prescription
Incompatibilities in prescription
 
Pharmaceutical Incompatibility
Pharmaceutical IncompatibilityPharmaceutical Incompatibility
Pharmaceutical Incompatibility
 
P.formulations solutions
P.formulations    solutionsP.formulations    solutions
P.formulations solutions
 
Drug Excipient Interaction Studies
Drug Excipient Interaction StudiesDrug Excipient Interaction Studies
Drug Excipient Interaction Studies
 
UNIT II - LIQUIDS.pptx
UNIT II -  LIQUIDS.pptxUNIT II -  LIQUIDS.pptx
UNIT II - LIQUIDS.pptx
 
Prodrug
ProdrugProdrug
Prodrug
 
Drug incompatibilities
Drug  incompatibilitiesDrug  incompatibilities
Drug incompatibilities
 
SOLUBILIZATION TECHNIQUES
SOLUBILIZATION TECHNIQUESSOLUBILIZATION TECHNIQUES
SOLUBILIZATION TECHNIQUES
 
12 incompatability
12 incompatability12 incompatability
12 incompatability
 
Incompatibility in Prescription
Incompatibility in PrescriptionIncompatibility in Prescription
Incompatibility in Prescription
 
Pharmaceutical incompatibility
Pharmaceutical incompatibilityPharmaceutical incompatibility
Pharmaceutical incompatibility
 
prodrug-.pptx Medicinal chemistry 7 SEMESTER
prodrug-.pptx  Medicinal chemistry 7 SEMESTERprodrug-.pptx  Medicinal chemistry 7 SEMESTER
prodrug-.pptx Medicinal chemistry 7 SEMESTER
 
Accelerated Stability Testing.
Accelerated Stability Testing. Accelerated Stability Testing.
Accelerated Stability Testing.
 
Drug excipient compatibility
Drug excipient compatibilityDrug excipient compatibility
Drug excipient compatibility
 
Oral Solutions Dr.pptx
Oral Solutions Dr.pptxOral Solutions Dr.pptx
Oral Solutions Dr.pptx
 

More from Sudipta Roy

Communicable Diseases-WPS Office.pdf
Communicable Diseases-WPS Office.pdfCommunicable Diseases-WPS Office.pdf
Communicable Diseases-WPS Office.pdf
Sudipta Roy
 
OTC Medicine-WPS Office.pdf
OTC Medicine-WPS Office.pdfOTC Medicine-WPS Office.pdf
OTC Medicine-WPS Office.pdf
Sudipta Roy
 
Inventory control-WPS Office.pdf
Inventory control-WPS Office.pdfInventory control-WPS Office.pdf
Inventory control-WPS Office.pdf
Sudipta Roy
 
List of Application and community pharmacy management-WPS Office.pdf
List of Application and community pharmacy management-WPS Office.pdfList of Application and community pharmacy management-WPS Office.pdf
List of Application and community pharmacy management-WPS Office.pdf
Sudipta Roy
 
Community Pharmacy management-WPS Office.pdf
Community Pharmacy management-WPS Office.pdfCommunity Pharmacy management-WPS Office.pdf
Community Pharmacy management-WPS Office.pdf
Sudipta Roy
 
Medication Adherence-WPS Office.pdf
Medication Adherence-WPS Office.pdfMedication Adherence-WPS Office.pdf
Medication Adherence-WPS Office.pdf
Sudipta Roy
 
Healthcare Screeninng services-WPS Office.pdf
Healthcare Screeninng services-WPS Office.pdfHealthcare Screeninng services-WPS Office.pdf
Healthcare Screeninng services-WPS Office.pdf
Sudipta Roy
 
Fry Graph -WPS Office.pdf
Fry Graph  -WPS Office.pdfFry Graph  -WPS Office.pdf
Fry Graph -WPS Office.pdf
Sudipta Roy
 
Patient Information leaflets-WPS Office.pdf
Patient Information leaflets-WPS Office.pdfPatient Information leaflets-WPS Office.pdf
Patient Information leaflets-WPS Office.pdf
Sudipta Roy
 
Patient Information-WPS Office.pdf
Patient Information-WPS Office.pdfPatient Information-WPS Office.pdf
Patient Information-WPS Office.pdf
Sudipta Roy
 
Patient counsel case study-WPS Office.pdf
Patient counsel case study-WPS Office.pdfPatient counsel case study-WPS Office.pdf
Patient counsel case study-WPS Office.pdf
Sudipta Roy
 
Patient Couenseling-WPS Office.pdf
Patient Couenseling-WPS Office.pdfPatient Couenseling-WPS Office.pdf
Patient Couenseling-WPS Office.pdf
Sudipta Roy
 
Prescription1-WPS Office.pdf
Prescription1-WPS Office.pdfPrescription1-WPS Office.pdf
Prescription1-WPS Office.pdf
Sudipta Roy
 
Case Study1-WPS Office.pdf
Case Study1-WPS Office.pdfCase Study1-WPS Office.pdf
Case Study1-WPS Office.pdf
Sudipta Roy
 
Case Study-WPS Office.pdf
Case Study-WPS Office.pdfCase Study-WPS Office.pdf
Case Study-WPS Office.pdf
Sudipta Roy
 
Pharmaceutical care-WPS Office.pdf
Pharmaceutical care-WPS Office.pdfPharmaceutical care-WPS Office.pdf
Pharmaceutical care-WPS Office.pdf
Sudipta Roy
 
Community Pharmacy-WPS Office.pdf
Community Pharmacy-WPS Office.pdfCommunity Pharmacy-WPS Office.pdf
Community Pharmacy-WPS Office.pdf
Sudipta Roy
 
Skin Creams..7-WPS Office.pdf
Skin Creams..7-WPS Office.pdfSkin Creams..7-WPS Office.pdf
Skin Creams..7-WPS Office.pdf
Sudipta Roy
 
Pharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdfPharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdf
Sudipta Roy
 
Role of Pharmacists in Eradication and prevention 1-WPS Office.pptx
Role of Pharmacists in Eradication and prevention 1-WPS Office.pptxRole of Pharmacists in Eradication and prevention 1-WPS Office.pptx
Role of Pharmacists in Eradication and prevention 1-WPS Office.pptx
Sudipta Roy
 

More from Sudipta Roy (20)

Communicable Diseases-WPS Office.pdf
Communicable Diseases-WPS Office.pdfCommunicable Diseases-WPS Office.pdf
Communicable Diseases-WPS Office.pdf
 
OTC Medicine-WPS Office.pdf
OTC Medicine-WPS Office.pdfOTC Medicine-WPS Office.pdf
OTC Medicine-WPS Office.pdf
 
Inventory control-WPS Office.pdf
Inventory control-WPS Office.pdfInventory control-WPS Office.pdf
Inventory control-WPS Office.pdf
 
List of Application and community pharmacy management-WPS Office.pdf
List of Application and community pharmacy management-WPS Office.pdfList of Application and community pharmacy management-WPS Office.pdf
List of Application and community pharmacy management-WPS Office.pdf
 
Community Pharmacy management-WPS Office.pdf
Community Pharmacy management-WPS Office.pdfCommunity Pharmacy management-WPS Office.pdf
Community Pharmacy management-WPS Office.pdf
 
Medication Adherence-WPS Office.pdf
Medication Adherence-WPS Office.pdfMedication Adherence-WPS Office.pdf
Medication Adherence-WPS Office.pdf
 
Healthcare Screeninng services-WPS Office.pdf
Healthcare Screeninng services-WPS Office.pdfHealthcare Screeninng services-WPS Office.pdf
Healthcare Screeninng services-WPS Office.pdf
 
Fry Graph -WPS Office.pdf
Fry Graph  -WPS Office.pdfFry Graph  -WPS Office.pdf
Fry Graph -WPS Office.pdf
 
Patient Information leaflets-WPS Office.pdf
Patient Information leaflets-WPS Office.pdfPatient Information leaflets-WPS Office.pdf
Patient Information leaflets-WPS Office.pdf
 
Patient Information-WPS Office.pdf
Patient Information-WPS Office.pdfPatient Information-WPS Office.pdf
Patient Information-WPS Office.pdf
 
Patient counsel case study-WPS Office.pdf
Patient counsel case study-WPS Office.pdfPatient counsel case study-WPS Office.pdf
Patient counsel case study-WPS Office.pdf
 
Patient Couenseling-WPS Office.pdf
Patient Couenseling-WPS Office.pdfPatient Couenseling-WPS Office.pdf
Patient Couenseling-WPS Office.pdf
 
Prescription1-WPS Office.pdf
Prescription1-WPS Office.pdfPrescription1-WPS Office.pdf
Prescription1-WPS Office.pdf
 
Case Study1-WPS Office.pdf
Case Study1-WPS Office.pdfCase Study1-WPS Office.pdf
Case Study1-WPS Office.pdf
 
Case Study-WPS Office.pdf
Case Study-WPS Office.pdfCase Study-WPS Office.pdf
Case Study-WPS Office.pdf
 
Pharmaceutical care-WPS Office.pdf
Pharmaceutical care-WPS Office.pdfPharmaceutical care-WPS Office.pdf
Pharmaceutical care-WPS Office.pdf
 
Community Pharmacy-WPS Office.pdf
Community Pharmacy-WPS Office.pdfCommunity Pharmacy-WPS Office.pdf
Community Pharmacy-WPS Office.pdf
 
Skin Creams..7-WPS Office.pdf
Skin Creams..7-WPS Office.pdfSkin Creams..7-WPS Office.pdf
Skin Creams..7-WPS Office.pdf
 
Pharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdfPharmacoeconomics5-WPS Office.pdf
Pharmacoeconomics5-WPS Office.pdf
 
Role of Pharmacists in Eradication and prevention 1-WPS Office.pptx
Role of Pharmacists in Eradication and prevention 1-WPS Office.pptxRole of Pharmacists in Eradication and prevention 1-WPS Office.pptx
Role of Pharmacists in Eradication and prevention 1-WPS Office.pptx
 

Recently uploaded

"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi
Fwdays
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
Alan Dix
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Tobias Schneck
 
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptxIOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
Abida Shariff
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
Elena Simperl
 
DevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA ConnectDevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA Connect
Kari Kakkonen
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
Cheryl Hung
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
Laura Byrne
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance
 
The Future of Platform Engineering
The Future of Platform EngineeringThe Future of Platform Engineering
The Future of Platform Engineering
Jemma Hussein Allen
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
James Anderson
 
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualitySoftware Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Inflectra
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
DianaGray10
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
Prayukth K V
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
Alison B. Lowndes
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Jeffrey Haguewood
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
Product School
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
RTTS
 

Recently uploaded (20)

"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi"Impact of front-end architecture on development cost", Viktor Turskyi
"Impact of front-end architecture on development cost", Viktor Turskyi
 
Epistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI supportEpistemic Interaction - tuning interfaces to provide information for AI support
Epistemic Interaction - tuning interfaces to provide information for AI support
 
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024
 
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptxIOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
IOS-PENTESTING-BEGINNERS-PRACTICAL-GUIDE-.pptx
 
Knowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and backKnowledge engineering: from people to machines and back
Knowledge engineering: from people to machines and back
 
DevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA ConnectDevOps and Testing slides at DASA Connect
DevOps and Testing slides at DASA Connect
 
Key Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdfKey Trends Shaping the Future of Infrastructure.pdf
Key Trends Shaping the Future of Infrastructure.pdf
 
The Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and SalesThe Art of the Pitch: WordPress Relationships and Sales
The Art of the Pitch: WordPress Relationships and Sales
 
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdfFIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
FIDO Alliance Osaka Seminar: FIDO Security Aspects.pdf
 
FIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdfFIDO Alliance Osaka Seminar: Overview.pdf
FIDO Alliance Osaka Seminar: Overview.pdf
 
The Future of Platform Engineering
The Future of Platform EngineeringThe Future of Platform Engineering
The Future of Platform Engineering
 
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...
 
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered QualitySoftware Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
Software Delivery At the Speed of AI: Inflectra Invests In AI-Powered Quality
 
UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3UiPath Test Automation using UiPath Test Suite series, part 3
UiPath Test Automation using UiPath Test Suite series, part 3
 
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 previewState of ICS and IoT Cyber Threat Landscape Report 2024 preview
State of ICS and IoT Cyber Threat Landscape Report 2024 preview
 
Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........Bits & Pixels using AI for Good.........
Bits & Pixels using AI for Good.........
 
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdfFIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf
 
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...
 
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
De-mystifying Zero to One: Design Informed Techniques for Greenfield Innovati...
 
JMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and GrafanaJMeter webinar - integration with InfluxDB and Grafana
JMeter webinar - integration with InfluxDB and Grafana
 

Pharmaceutical-WPS Office(Conflict2022-05-23-13-29-31).pptx

  • 2. Definition of Incompatibility. Incompatibility: Formation of Changed and Undesirable product. There are three types of Pharmaceutical Incompatibilities seen due to changes and undesirable effects-Physical,Chemical and therapeutic incompatibilities to affect the safety,efficacy, appearance and stability of the product.
  • 3. Reasons of Pharmaceutical Incompatibilities. • Formation of Undesirable product are due to • Compounding • Formulation • Manufacturing • Packaging • Dispensing • Storage • Administration of drugs
  • 4. The pharmaeutical incompatibilities may be changed due to physical, chemical, and therapeutic qualities of the medicine.
  • 5. Physical incompatibilities. • Two or more than two substances are combined, a physical change takes place and unacceptable product is formed. • Interaction between two or more substances lead to change in color, odor , taste , viscosity and morphology.
  • 6. Reasons of Physical Incompatibility. Insolubility:-Insolubility of prescribed agents in vehicle. Immiscibility:-Immiscibility of two or more liquids. Precipitation:-It occurs due to solvent is insoluble when it is added to solution. Liquefaction:-Liquefaction of solids mixed in a dry state (called eutexia).
  • 7. • INSOLUBILITY • Materials are not dissolved in particular solvent system. • Incompatibilities are due to insolubility of the inoeganic and organic compounds in particular solvent. • These are factors that affect insolubility. • Change in PH • Milling • Surfactant • Chemical reaction • Complex formation • Co-solvent
  • 8. Common Examples of Diffusible Solids: Substances like chalk, acetyl salicylic acid ,succinyl sulphothiazzole, zinc oxide, and calamine etc.
  • 9. Tinctures containing resins or chlorophyll gets precipitated when added to the aqueous system. E.g.:-Mixture of prepared chalk Rx Chalk powder –2g Tincture catechu – 2ml Cinnamon water – 2ml
  • 10. Causes: - Chalk powder is insoluble in water , due to this It gets precipitated into aqueous medium,diffusible in nature which results in physical incompatibility. Remedy: - Use of suspending agents are necessary to suspend the precipitated chalk particles.
  • 11. Generally 2% W/V of compound tragacanth powder is recommended as suspending agent. • The corrected prescription is Mixture of prepared chalk • Rx • Chalk powder –2g • Tragacanth – 0.4g • Tincture catechu – 2ml • Cinnamon water up to 30ml